Citi Veterinary Pharma Limited to raise capital, expanding company’s footprint in Pakistan’s animal health sector
KARACHI: Citi Pharma Limited, one of Pakistan’s leading pharmaceutical companies, has announced plans to launch an initial public offering (IPO) for its wholly owned subsidiary, Citi Veterinary Pharma Limited (CVPL), signaling a major step in the company’s strategy to diversify its revenue streams.
The announcement, shared with the Pakistan Stock Exchange (PSX) on Tuesday, stated that the Board of Directors of Citi Pharma has formally approved the IPO, with K-Trade Securities Limited appointed as the consultant to facilitate the issuance and listing of CVPL at the earliest opportunity.
CVPL is focused on veterinary pharmaceuticals, specializing in the production of veterinary active pharmaceutical ingredients (APIs) and other related products for the domestic market. Through this IPO, Citi Pharma aims to raise between Rs1 billion and Rs2 billion, supporting its expansion in the fast-growing veterinary sector.
“This marks a significant milestone in Citi Pharma’s diversification strategy, enhancing revenue potential beyond the traditional pharmaceutical business. For FY26, the company anticipates generating approximately Rs1.50 billion in revenue from veterinary product trading,” the notice added.
The IPO initiative follows Citi Pharma’s recent foray into Pakistan’s real estate sector. Last month, the company secured approval from the Securities and Exchange Commission of Pakistan (SECP) to establish a wholly owned REIT management subsidiary, CITI REIT Management Company (Private) Limited. Under this platform, the company plans to undertake three major development projects: one on Hali Road, Lahore, a second on Khayaban-e-Zafar, Lahore, and a third near Islamabad International Airport. With these strategic moves, Citi Pharma is positioning itself not only as a leader in human and veterinary pharmaceuticals but also as a diversified investment player in real estate, reflecting a bold approach to business growth in Pakistan.
